[
    [
        {
            "time": "",
            "original_text": "信立泰、石药、正大天晴PK阿斯利康！10亿大品种“1+3”格局形成",
            "features": {
                "keywords": [
                    "信立泰",
                    "石药",
                    "正大天晴",
                    "阿斯利康",
                    "10亿大品种",
                    "市场竞争"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "信立泰、石药、正大天晴PK阿斯利康！10亿大品种“1+3”格局形成",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-07-30",
            "original_text": "上海证券市场大宗交易公开信息(2019-07-30)",
            "features": {
                "keywords": [
                    "上海证券市场",
                    "大宗交易",
                    "公开信息"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海证券市场大宗交易公开信息(2019-07-30)",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 2,
                "Headline_Structure": 3,
                "Source_Recency": 1
            }
        },
        {
            "time": "",
            "original_text": "467倍！微芯生物的发行市盈率为何能刷新科创板记录",
            "features": {
                "keywords": [
                    "微芯生物",
                    "发行市盈率",
                    "科创板",
                    "467倍"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "467倍！微芯生物的发行市盈率为何能刷新科创板记录",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医疗保健：顾盼大分子市场 荐6股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "大分子市场",
                    "荐股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗保健：顾盼大分子市场 荐6股",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "PD-1抑制剂专题报告:百舸争流,PD-1之争谁能胜出",
            "features": {
                "keywords": [
                    "PD-1抑制剂",
                    "专题报告",
                    "市场竞争",
                    "生物医药"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "PD-1抑制剂专题报告:百舸争流,PD-1之争谁能胜出",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]